New drug combo targets tough cancers in early trial
NCT ID NCT07181681
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 28 times
Summary
This early-phase study tests a new drug called BG-C0902 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to target and kill cancer cells while sparing healthy ones. The main goals are to check safety, find the right dose, and see if it shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Blacktown Cancer and Haematology Centre
RECRUITINGBlacktown, New South Wales, NSW 2148, Australia
-
Chongqing University Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, 400030, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450000, China
-
Monash Health
RECRUITINGClayton, Victoria, VIC 3168, Australia
-
Next Oncology
RECRUITINGSan Antonio, Texas, 78229-6028, United States
-
Next Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Rui Jin Hospital Shanghai Jiao Tong University School of Medicinejiading Branch
RECRUITINGShanghai, Shanghai Municipality, 201801, China
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, VIC 3004, Australia
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, 361003, China
-
The University of Texas Md Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-4009, United States
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.